These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 8228332)

  • 1. Vitamin D3 and calcipotriol decrease extracellular plasminogen activator activity in cultured keratinocytes.
    Koli K; Keski-Oja J
    J Invest Dermatol; 1993 Nov; 101(5):706-12. PubMed ID: 8228332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced production of plasminogen activator activity in human and murine keratinocytes by transforming growth factor-beta 1.
    Keski-Oja J; Koli K
    J Invest Dermatol; 1992 Aug; 99(2):193-200. PubMed ID: 1629632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin D3 and calcipotriol enhance the secretion of transforming growth factor-beta 1 and -beta 2 in cultured murine keratinocytes.
    Koli K; Keski-Oja J
    Growth Factors; 1993; 8(2):153-63. PubMed ID: 8466756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of urokinase-type plasminogen activator and plasminogen activator inhibitor-2 expression by U-937 mononuclear phagocytes. Effects of 1 alpha, 25-dihydroxyvitamin D3 and phorbol ester.
    Gyetko MR; Webb AC; Sitrin RG
    J Immunol; 1988 Oct; 141(8):2693-8. PubMed ID: 3139763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin D3 regulation of transforming growth factor-beta system in epithelial and fibroblastic cells--relationships to plasminogen activation.
    Koli K; Keski-Oja J
    J Investig Dermatol Symp Proc; 1996 Apr; 1(1):33-8. PubMed ID: 9627689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of calcipotriol with selected metabolites and analogues of vitamin D3: effects on cell growth regulation in vitro and calcium metabolism in vivo.
    Binderup L
    Pharmacol Toxicol; 1993; 72(4-5):240-4. PubMed ID: 8396769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Similarly potent action of 1,25-dihydroxyvitamin D3 and its analogues, tacalcitol, calcipotriol, and maxacalcitol on normal human keratinocyte proliferation and differentiation.
    Takahashi H; Ibe M; Kinouchi M; Ishida-Yamamoto A; Hashimoto Y; Iizuka H
    J Dermatol Sci; 2003 Feb; 31(1):21-8. PubMed ID: 12615360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential regulation of plasminogen activation in normal keratinocytes and SCC-4 cells by fibroblasts.
    Boxman IL; Quax PH; Löwik CW; Papapoulos SE; Verheijen J; Ponec M
    J Invest Dermatol; 1995 Mar; 104(3):374-8. PubMed ID: 7861005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of tissue plasminogen activator and plasminogen activator inhibitor-1 by transforming growth factor-beta in human retinal glial cells.
    Schacke W; Beck KF; Pfeilschifter J; Koch F; Hattenbach LO
    Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2799-805. PubMed ID: 12147618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcipotriol (MC 903), a novel vitamin D3 analogue stimulates terminal differentiation and inhibits proliferation of cultured human keratinocytes.
    Kragballe K; Wildfang IL
    Arch Dermatol Res; 1990; 282(3):164-7. PubMed ID: 2164359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The vitamin D3 analogue, calcipotriol, induces sphingomyelin hydrolysis in human keratinocytes.
    Geilen CC; Bektas M; Wieder T; Orfanos CE
    FEBS Lett; 1996 Jan; 378(1):88-92. PubMed ID: 8549810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1alpha,25-dihydroxyvitamin D3 and its analogues down-regulate cell invasion-associated proteases in cultured malignant cells.
    Koli K; Keski-Oja J
    Cell Growth Differ; 2000 Apr; 11(4):221-9. PubMed ID: 10775039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming growth factor-beta modulates plasminogen activator activity and plasminogen activator inhibitor type-1 expression in human keratinocytes in vitro.
    Wikner NE; Elder JT; Persichitte KA; Mink P; Clark RA
    J Invest Dermatol; 1990 Nov; 95(5):607-13. PubMed ID: 2230225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor beta1 in the human endometrium. Cyclic variation, increased expression by estradiol and progesterone, and regulation of plasminogen activators and plasminogen activator inhibitor-1.
    Casslén B; Sandberg T; Gustavsson B; Willén R; Nilbert M
    Biol Reprod; 1998 Jun; 58(6):1343-50. PubMed ID: 9623591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulatory effects of 1,25-dihydroxyvitamin D3 and a novel vitamin D3 analogue MC903 on secretion of interleukin-1 alpha (IL-1 alpha) and IL-8 by normal human keratinocytes and a human squamous cell carcinoma cell line (HSC-1).
    Zhang JZ; Maruyama K; Ono I; Iwatsuki K; Kaneko F
    J Dermatol Sci; 1994 Feb; 7(1):24-31. PubMed ID: 8193081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of plasminogen activation by TGF-beta in cultured human retinal endothelial cells.
    Wileman SM; Booth NA; Moore N; Redmill B; Forrester JV; Knott RM
    Br J Ophthalmol; 2000 Apr; 84(4):417-22. PubMed ID: 10729302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proliferation and differentiation of cultured human keratinocytes is modulated by 1,25(OH)2D3 and synthetic vitamin D3 analogues in a cell density-, calcium- and serum-dependent manner.
    Svendsen ML; Daneels G; Geysen J; Binderup L; Kragballe K
    Pharmacol Toxicol; 1997 Jan; 80(1):49-56. PubMed ID: 9148283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of transforming growth factor-beta 1 and phorbol ester on PAI-1 and PA genes in human lung cells.
    Jakowlew SB; Mariano JM; You L
    Growth Factors; 1997; 14(2-3):177-97. PubMed ID: 9255608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-regulation of proteolytic activity in 12-O-tetradecanoyl-phorbol-13-acetate-induced K562 leukemia cell cultures: depletion of active urokinase by excess type 1 plasminogen activator inhibitor.
    Alitalo R; Andersson LC; Tapiovaara H; Sistonen L; Vaheri A; Stephens R
    J Cell Physiol; 1989 Jul; 140(1):119-30. PubMed ID: 2500450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasminogen activator inhibitor type-2 (PAI-2) in human keratinocytes regulates pericellular urokinase-type plasminogen activator.
    Reinartz J; Schaefer B; Bechtel MJ; Kramer MD
    Exp Cell Res; 1996 Feb; 223(1):91-101. PubMed ID: 8635500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.